Rapid Improvement in Refractory Acrodermatitis Continua of Hallopeau With Spesolimab Injection

We present a case of Acrodermatitis Continua of Hallopeau (ACH) who was resistant to traditional therapies such as acitretin, cyclosporine, methotrexate as well as secukinumab and ustekinumab, successfully treated with subcutaneous spesolimab, resulting in rapid resolution of skin lesions.